Edition:
United States

Profile: Covalon Technologies Ltd (COV.V)

COV.V on TSX Venture Exchange

1.65CAD
24 Nov 2016
Change (% chg)

$0.03 (+1.85%)
Prev Close
$1.62
Open
$1.65
Day's High
$1.65
Day's Low
$1.65
Volume
600
Avg. Vol
14,792
52-wk High
$2.85
52-wk Low
$0.72

Covalon Technologies Ltd. is a researcher, developer, manufacturer and marketer of medical products intended for wound care, infection management and surgical procedures. The Company's wound care dressing products include ColActive Plus, ColActive Transfer, CovaWound Silicone, CovaWound Silicone Sacrum, CovaWound Foam, CovaWound Alginate, CovaWound Super Absorbent and CovaWound Hydrocolloid. The Company's surgical and peri-operative products include SurgiClear, MediClear Post-Op Absorb and MediClear Scar. The Company's infection management products include IV Clear and SilverCoat Foley Catheter. The Company distributes products under the Covalon brand name. The Company also develops and commercializes medical products for other medical companies under development and license contracts. The Company's platform technologies include Collagen matrix, Antimicrobial silicone adhesive and Medical coating technology.

Company Address

Covalon Technologies Ltd

1660 Tech Ave Unit 5
MISSISSAUGA   ON   L4W 5S7
P: +1905.5688400
F: +1905.5685200

Company Web Links